BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 2670367)

  • 21. Chromoblastomycosis--a clinical and mycological study of 71 cases from Sri Lanka.
    Attapattu MC
    Mycopathologia; 1997; 137(3):145-51. PubMed ID: 9368408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.
    Criado PR; Careta MF; Valente NY; Martins JE; Rivitti EA; Spina R; Belda W
    J Dermatolog Treat; 2011 Jun; 22(3):167-74. PubMed ID: 20666671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphangitic chromoblastomycosis.
    Muhammed K; Nandakumar G; Asokan KK; Vimi P
    Indian J Dermatol Venereol Leprol; 2006; 72(6):443-5. PubMed ID: 17179621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
    Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of skin test for chromoblastomycosis using antigens prepared from culture filtrates of Fonsecaea pedrosoi, Phialophora verrucosa, Wangiella dermatitidis and Exophiala jeanselmei.
    Iwatsu T; Miyaji M; Taguchi H; Okamoto S
    Mycopathologia; 1982 Jan; 77(1):59-64. PubMed ID: 7070478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous mycoses in coastal Karnataka in south India.
    Bhat RM; Monteiro RC; Bala N; Dandakeri S; Martis J; Kamath GH; Kambil SM; Asha Vadakayil R
    Int J Dermatol; 2016 Jan; 55(1):70-8. PubMed ID: 26267755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar
    Rasamoelina T; Maubon D; Andrianarison M; Ranaivo I; Sendrasoa F; Rakotozandrindrainy N; Rakotomalala FA; Bailly S; Rakotonirina B; Andriantsimahavandy A; Rabenja FR; Andrianarivelo MR; Cornet M; Ramarozatovo LS
    Emerg Infect Dis; 2020 Jun; 26(6):1201-1211. PubMed ID: 32441639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.
    Santos AL; Palmeira VF; Rozental S; Kneipp LF; Nimrichter L; Alviano DS; Rodrigues ML; Alviano CS
    FEMS Microbiol Rev; 2007 Sep; 31(5):570-91. PubMed ID: 17645522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis.
    Garnica M; Nucci M; Queiroz-Telles F
    Curr Opin Infect Dis; 2009 Dec; 22(6):559-63. PubMed ID: 19773651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromoblastomycosis: clinical presentation and management.
    Ameen M
    Clin Exp Dermatol; 2009 Dec; 34(8):849-54. PubMed ID: 19575735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromoblastomycosis in Kerala, India.
    Chandran V; Sadanandan SM; Sobhanakumari K
    Indian J Dermatol Venereol Leprol; 2012; 78(6):728-33. PubMed ID: 23075642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific oligonucleotide primers for identification of Cladophialophora carrionii, a causative agent of chromoblastomycosis.
    Abliz P; Fukushima K; Takizawa K; Nishimura K
    J Clin Microbiol; 2004 Jan; 42(1):404-7. PubMed ID: 14715791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chromoblastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine.
    Sevigny GM; Ramos-Caro FA
    Cutis; 2000 Jul; 66(1):45-6. PubMed ID: 10916691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous dematiaceous fungal infection.
    Patel U; Chu J; Patel R; Meehan S
    Dermatol Online J; 2011 Oct; 17(10):19. PubMed ID: 22031645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dematiaceous fungal infections in China.
    Li R; Wang D; Dai W
    Curr Top Med Mycol; 1995; 6():283-305. PubMed ID: 8724249
    [No Abstract]   [Full Text] [Related]  

  • 36. Chromoblastomycosis.
    Krzyściak PM; Pindycka-Piaszczyńska M; Piaszczyński M
    Postepy Dermatol Alergol; 2014 Oct; 31(5):310-21. PubMed ID: 25395928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
    Queiroz-Telles F; Esterre P; Perez-Blanco M; Vitale RG; Salgado CG; Bonifaz A
    Med Mycol; 2009 Feb; 47(1):3-15. PubMed ID: 19085206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report: Fever- pneumonia- lymphadenectasis- osteolytic- subcutaneous nodule: Disseminated chromoblastomycosis caused by phialophora.
    Qiu Y; Zhang J; Tang Y; Zhong X; Deng J
    J Infect Chemother; 2019 Dec; 25(12):1031-1036. PubMed ID: 31229375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycetoma.
    Magaña M; Magaña-García M
    Dermatol Clin; 1989 Apr; 7(2):203-17. PubMed ID: 2670366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous fungal infections.
    Pang KR; Wu JJ; Huang DB; Tyring SK
    Dermatol Ther; 2004; 17(6):523-31. PubMed ID: 15571502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.